Xaira Therapeutics raised a massive $1B in funding led by ARCH Venture Partners and Foresite Labs for AI drug discovery

Apr 25, 2024•over 1 year ago

Amount Raised

$1 Billion

BrisbaneTherapeuticsMachine LearningArtificial IntelligenceBiotechnology

Investors

Sv AngelTwo Sigma VenturesMenlo VenturesLightspeed Venture PartnersLux CapitalSequoia CapitalNeaF PrimeForesite LabsArch Venture Partners

Description

Xaira Therapeutics, a startup specializing in AI drug discovery, has launched with a significant $1 billion funding round. The company aims to leverage recent AI breakthroughs to develop previously unattainable drugs.

Company Information

Company

Xaira Therapeutics

Location

Brisbane, California, United States

About

Xaira Therapeutics is an AI drug discovery startup that aims to develop drugs using recent breakthroughs in AI technology. The company was incubated by ARCH Venture Partners and Foresite Labs, with additional funding from F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, and SV Angel.

Related People

6 contacts

Funding Insights

Based on industry data

VC-backed spending patterns